Age related decline in aluminum-activated human platelet adenylate cyclase: Post-receptor changes in cyclic AMP second messenger signal amplification in normal aging and dementia of the Alzheimer type
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 39 (13), 1167-1175
- https://doi.org/10.1016/0024-3205(86)90348-6
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: Preliminary dataJournal of Psychiatric Research, 1985
- Acute desensitization of lymphocyte beta-adrenergic-stimulated adenylate cyclase in old age and Alzheimer's diseaseLife Sciences, 1984
- Neurotoxicity of aluminumCanadian Journal of Physiology and Pharmacology, 1984
- The dual effects of aluminum as activator and inhibitor of adenylate cyclase in the liver fluke Fasciola hepaticaBiochemical and Biophysical Research Communications, 1983
- Guanosine Triphosphate Activation of Brain Adenylate Cyclase: Enhancement by Long-Term Antidepressant TreatmentScience, 1983
- Intraneuronal Aluminum Accumulation in Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia of GuamScience, 1982
- Noncompetitive inhibition by aluminum, scandium and yttrium of acetylcholinesterase from Electrophorus electricusBiochemical Pharmacology, 1982
- Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.Journal of Clinical Pathology, 1981
- Triiodothyronine-induced Thyrotoxicosis Increases Mononuclear Leukocyte β-Adrenergic Receptor Density in ManJCI Insight, 1981
- The lymphocyte beta-adrenoceptor in normal subjects and patients with bronchial asthma: the effect of different forms of treatment on receptor function.JCI Insight, 1976